Teva Pharmaceutical advertising spend, FY2025
Teva Pharmaceutical (TEVA) reported $309M of advertising expense for the fiscal year ended Dec 31, 2025. That is 1.8% of revenue of $17.3B. Up 19.3% from FY2024. Formerly Teva Pharmaceutical Industries.
Key facts
- Ad spend is 1.4x its FY2020 level ($225M), faster than revenue (1.0x).
- The highest year on file is FY2012 at $337M; FY2025 is 8% below it.
- Largest increase +143.7% in FY2009; largest cut -31.7% in FY2022.
- Ad spend has risen 2 years in a row.
- Ad spend is 1.8% of revenue, up from 1.4% in FY2020.
- Teva Pharmaceutical spends more on advertising than 64% of the 458 US-listed companies tracked. Its ad-to-revenue ratio is below the median of 4.5%.
Ad spend by fiscal year
Ad spend as % of revenue
Ad spend in context, FY2025
Research and development spending was 3.3x advertising. Advertising equalled 14.3% of operating income.
| Advertising | $309M | AdvertisingExpense |
|---|---|---|
| Selling and marketing | $2.7B | ad spend = 11.5% |
| Research and development | $1B | R&D = 3.3x ad spend |
| Operating income | $2.2B | ad spend = 14.3% |
| Net income | $1.4B |
Same fiscal year and filing as the ad spend. Selling and marketing and SG&A usually include advertising.
History
Download CSV| Fiscal year | Period end | Ad spend | YoY | Revenue | Ad / revenue | Tag | Filing |
|---|---|---|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | $309M | +19.3% | $17.3B | 1.8% | AdvertisingExpense | 10-K Feb 3, 2026 |
| FY2024 | Dec 31, 2024 | $259M | +59.9% | $16.5B | 1.6% | AdvertisingExpense | 10-K Feb 3, 2026 |
| FY2023 | Dec 31, 2023 | $162M | -3.6% | $15.8B | 1.0% | AdvertisingExpense | 10-K Feb 3, 2026 |
| FY2022 | Dec 31, 2022 | $168M | -31.7% | $14.9B | 1.1% | AdvertisingExpense | 10-K Feb 5, 2025 |
| FY2021 | Dec 31, 2021 | $246M | +9.3% | $15.9B | 1.5% | AdvertisingExpense | 10-K Feb 12, 2024 |
| FY2020 | Dec 31, 2020 | $225M | +5.6% | $16.7B | 1.4% | AdvertisingExpense | 10-K Feb 10, 2023 |
| FY2019 | Dec 31, 2019 | $213M | -16.8% | $16.9B | 1.3% | AdvertisingExpense | 10-K Feb 9, 2022 |
| FY2018 | Dec 31, 2018 | $256M | -19.5% | $18.3B | 1.4% | AdvertisingExpense | 10-K Feb 10, 2021 |
| FY2017 | Dec 31, 2017 | $318M | +1.9% | $21.9B | 1.5% | AdvertisingExpense | 10-K Feb 21, 2020 |
| FY2016 | Dec 31, 2016 | $312M | n/a | $21.9B | 1.4% | AdvertisingExpense | 10-K Feb 19, 2019 |
| FY2013 | Dec 31, 2013 | $321M | -4.7% | $20.3B | 1.6% | AdvertisingExpense | 20-F Feb 10, 2014 |
| FY2012 | Dec 31, 2012 | $337M | +35.9% | $20.3B | 1.7% | AdvertisingExpense | 20-F Feb 10, 2014 |
| FY2011 | Dec 31, 2011 | $248M | +2.1% | $18.3B | 1.4% | AdvertisingExpense | 20-F Feb 10, 2014 |
| FY2010 | Dec 31, 2010 | $243M | +14.6% | $16.1B | 1.5% | AdvertisingExpense | 20-F Feb 12, 2013 |
| FY2009 | Dec 31, 2009 | $212M | +143.7% | $13.9B | 1.5% | AdvertisingExpense | 20-F Feb 17, 2012 |
| FY2008 | Dec 31, 2008 | $87M | n/a | $11.1B | 0.8% | AdvertisingExpense | 20-F Feb 15, 2011 |
Ad spend, revenue and the ratio come from the linked filing. YoY compares each year with the fiscal year directly before it, under the same tag. A gap, a change of tag or a change of fiscal year end leaves it blank.
What the figure is
Advertising costs as disclosed in the annual report (XBRL tag AdvertisingExpense).
Compared with similar spenders
The 6 companies closest to Teva Pharmaceutical in latest-year ad spend.
| Rank | Company | Ad spend | Ad / revenue | YoY | Fiscal year |
|---|---|---|---|---|---|
| 163 | Celsius | $319M | 12.7% | +43.9% | FY2025 |
| 164 | Hasbro | $317M | 5.9% | -0.8% | FY2025 |
| 165 | Elanco Animal Health | $314M | 6.7% | +33.1% | FY2025 |
| 166 | Teva Pharmaceutical | $309M | 1.8% | +19.3% | FY2025 |
| 167 | Abercrombie & Fitch | $308M | 5.9% | +13.9% | FY2026 |
| 168 | Zoetis | $308M | 3.3% | +2.0% | FY2025 |
| 169 | Truist Financial | $299M | 1.5% | +11.6% | FY2025 |
Questions
How much does Teva Pharmaceutical spend on advertising?
Teva Pharmaceutical spent $309M on advertising in fiscal 2025, the year ended Dec 31, 2025, according to its 10-K filed Feb 3, 2026.
What percentage of revenue does Teva Pharmaceutical spend on advertising?
1.8% of revenue in fiscal 2025 ($309M against $17.3B). The median across the 458 companies tracked is 4.5%.
Is Teva Pharmaceutical spending more on advertising?
Yes. Ad spend rose 19.3% in fiscal 2025 from fiscal 2024. It has risen 2 years in a row.
How does Teva Pharmaceutical rank by advertising spend?
#166 of 458 US-listed companies with $50M or more in ad spend, ranked on each company's latest fiscal year.
Does Teva Pharmaceutical spend more on advertising than on R&D?
No. In fiscal 2025 it spent $1B on research and development and $309M on advertising.
What does Teva Pharmaceutical's advertising figure include?
Advertising costs as disclosed in the annual report (XBRL tag AdvertisingExpense).
Company and source
- Filing
- 10-K for FY2025, filed Feb 3, 2026
- Accession number
0001193125-26-034532- Company
- TEVA PHARMACEUTICAL INDUSTRIES LTD, CIK 818686, SIC 2834 (Pharmaceutical Preparations)
- Former names
- Teva Pharmaceutical Industries
- Headquarters
- Tel Aviv
- Incorporated in
- L3
- Fiscal year ends
- December 31
- Listed on
- NYSE
- SEC filer status
- Large accelerated filer
- Data
- SEC EDGAR XBRL company facts, retrieved Nov 18, 2026. Methodology.
- Cite
- Teva Pharmaceutical advertising spend, FY2008-FY2025. Aleksei Trudov, io.trudov.com, from SEC EDGAR XBRL company facts (latest: 10-K filed Feb 3, 2026), retrieved Nov 18, 2026. https://io.trudov.com/company/teva-pharmaceutical-industries/advertising-spend/
- Download
- CSV, all years · CSV, all 458 companies